BAX stock icon

Baxter International
BAX

$33.74
1.44%
 

About: Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.

Employees: 60,000

0
Funds holding %
of 6,689 funds
0
Analysts bullish %
of 7 analysts
0
News positive %
of 9 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

66% more call options, than puts

Call options by funds: $179M | Put options by funds: $108M

38% more funds holding in top 10

Funds holding in top 10: 8 [Q4 2023] → 11 (+3) [Q1 2024]

8% more capital invested

Capital invested by funds: $17.7B [Q4 2023] → $19.2B (+$1.45B) [Q1 2024]

1% more funds holding

Funds holding: 884 [Q4 2023] → 893 (+9) [Q1 2024]

9% more first-time investments, than exits

New positions opened: 109 | Existing positions closed: 100

7% less repeat investments, than reductions

Existing positions increased: 294 | Existing positions reduced: 315

2.02% less ownership

Funds ownership: 90.29% [Q4 2023] → 88.27% (-2.02%) [Q1 2024]

Research analyst outlook

7 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$36
7%
upside
Avg. target
$43
27%
upside
High target
$54
60%
upside

7 analyst ratings

positive
14%
neutral
86%
negative
0%
Goldman Sachs
David Roman
7%upside
$36
Neutral
Initiated
30 May 2024
Citigroup
Joanne Wuensch
13%upside
$38
Neutral
Maintained
22 May 2024
TD Cowen
Joshua Jennings
19%upside
$40
Hold
Downgraded
10 May 2024
Citigroup
Joanne Wuensch
30%upside
$44
Neutral
Maintained
3 Apr 2024
B of A Securities
Travis Steed
33%upside
$45
Neutral
Maintained
5 Mar 2024

Financial journalist opinion

Based on 9 articles about BAX published over the past 30 days